Today's Pre-Open Stock Movers:

Co-Diagnostics, Inc. (NASDAQ: CODX) 81.8% HIGHER; sees added gains as coronavirus play

GAIN Capital Holdings, Inc. (NYSE: GCAP) 68% HIGHER; announced it has entered into a definitive agreement to be acquired by INTL FCStone Inc. (NASDAQ: INTL). Under the terms of the agreement, INTL FCStone will acquire the Company in an all-cash transaction. The Company's stockholders will receive $6.00 per share, representing approximately $236 million in equity value.

Alpha Pro Tech, Ltd. (NYSE: APT) 55.4% HIGHER; announced an update to the status of orders booked for APTs proprietary N-95 Particulate Respirator face mask. As previously reported, over the last month, APT has ramped up production of the companys N-95 face mask, which is manufactured by APT in the United States with material sourced domestically, in response to a significant increase in customer demand resulting from the outbreak of the coronavirus (Covid-19).

Vir Biotechnology Inc. (NASDAQ: VIR) 48.7% HIGHER; Extends Yesterday's Gain

Vaxart, Inc. (NASDAQ: VXRT) 31.5% HIGHER; sees added gains as coronavirus play

Anaplan, Inc. (NYSE: PLAN) 28% LOWER; reported Q4 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $98.2 million versus the consensus estimate of $97.15 million.

Moderna, Inc. (NASDAQ: MRNA) 23.5% HIGHER; sees added gains as coronavirus play

Novavax, Inc. (NASDAQ: NVAX) 20.4% HIGHER; sees added gains as coronavirus play

Nutanix (NASDAQ: NTNX) 17.3% LOWER; reported Q2 EPS of ($0.60), $0.09 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $346.8 million versus the consensus estimate of $341.09 million. Nutanix sees Q3 2020 EPS of ($0.89), versus the consensus of ($0.74).

Continental Resources (NYSE: CLR) 16.3% LOWER; reported Q4 EPS of $0.55, $0.03 better than the analyst estimate of $0.52.

Teladoc (NYSE: TDOC) 15.4% HIGHER; reported Q4 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $156.49 million versus the consensus estimate of $152.95 million. Teladoc sees Q1 2020 EPS of ($0.37)-($0.34), versus the consensus of ($0.36). Teladoc sees Q1 2020 revenue of $169-172 million, versus the consensus of $163.88 million. Teladoc sees FY2020 EPS of ($1.19)-($1.06), versus the consensus of ($1.19). Teladoc sees FY2020 revenue of $695-710 million, versus the consensus of $692.86 million.

Medifast (NYSE: MED) 14.3% LOWER; reported Q4 EPS of $1.66, $0.59 better than the analyst estimate of $1.07. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $161.69 million. Medifast sees Q1 2020 EPS of $1.35-$1.42, versus the consensus of $1.61. Medifast sees Q1 2020 revenue of $166-171 million, versus the consensus of $175.63 million. Medifast sees FY2020 EPS of $6.25-$6.55, versus the consensus of $6.70. Medifast sees FY2020 revenue of $715-745 million, versus the consensus of $782.29 million.

Allied Esports Entertainment, Inc. (NASDAQ: AESE) 13.2% HIGHER; announced that it will not proceed with the public offering of its common stock previously announced on January 29, 2020. The Company will withdraw its registration statement on Form S-1 (File No. 333-235602) relating to the proposed offering, which had previously been filed with the U.S. Securities and Exchange Commission, but has not yet become effective.

QEP Resources, Inc. (NYSE: QEP) 12.4% LOWER; reported fourth quarter and full year 2019 financial and operating results and provided initial 2020 guidance and capital investment plan.

Natera (NASDAQ: NTRA) 12.2% HIGHER; reported Q4 EPS of ($0.46), $0.09 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $83.2 million versus the consensus estimate of $77.83 million. Natera sees FY2020 revenue of $335-350 million, versus the consensus of $334.88 million.

Crocs (NASDAQ: CROX) 12.1% LOWER; reported Q4 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $263 million versus the consensus estimate of $260.08 million. Crocs sees Q1 2020 revenue of $305-325 million, versus the consensus of $342.9 million.

Carvana Co. (NYSE: CVNA) 11.4% LOWER; reported Q4 EPS of ($0.79), $0.16 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion. Carvana Co. sees FY2020 revenue of $5.6-5.8 billion, versus the consensus of $6.03 billion.

Etsy (NASDAQ: ETSY) 10.8% HIGHER; reported Q4 EPS of $0.25, $0.09 better than the analyst estimate of $0.16. Revenue for the quarter came in at $270 million versus the consensus estimate of $264.91 million. Etsy sees 2020 revenue of $1.04-1.06 billion, versus the consensus of $1.02 billion.

CEL-SCI Corporation (NYSE: CVM) 9.8% HIGHER; issued a letter to its shareholders. Says multikine study to continue.

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) 9.6% LOWER; intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the underwritten public offering are to be sold by Oramed. Oramed intends to grant the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price, less the underwriting discount.

Elastic N.V. (NYSE: ESTC) 8.9% HIGHER; reported Q3 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $113.2 million versus the consensus estimate of $107.33 million. Elastic N.V. sees Q4 2020 EPS of ($0.32)-($0.30), versus the consensus of ($0.33). Elastic N.V. sees Q4 2020 revenue of $119-120 million, versus the consensus of $118.35 million.

Box (NYSE: BOX) 8.8% HIGHER; reported Q4 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $183.6 million versus the consensus estimate of $181.63 million. Box sees Q1 2021 EPS of $0.04-$0.06, versus the consensus of $0.03. Box sees Q1 2021 revenue of $183-184 million, versus the consensus of $191.8 million. Box sees FY2021 EPS of $0.38-$0.44, versus the consensus of $0.29. Box sees FY2021 revenue of $771-777 million, versus the consensus of $773 million.

Square (NYSE: SQ) 7.7% HIGHER; reported Q4 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Total net revenue grew 41% year over year to $1.31 billion, and gross profit grew 39% year over year to $527 million. Square sees Q1 2020 EPS of $0.16-$0.18, versus the consensus of $0.16. Square sees Q1 2020 revenue of $1.34-1.36 billion. Square sees FY2020 EPS of $0.90-$0.94, versus the consensus of $0.95. Square sees FY2020 revenue of $5.9-5.96 billion.